Assisted Reproductive Technology Market to Expand 1.4X by 2025, as Public Grants Offset Costs
Advancements in fertilization technology and improved access to fertility clinics, worldwide, continue to boost reproductive success. In the U.S., infertility treatment grants offered by organisations such as the Angels of Hope Foundation, Pay-it-Forward Foundation, and BabyQuest Foundation allow for cost-intensive fertility treatment to be availed by all. Progressive improvements in reproductive outcomes are reflecting on the growing reliance of couples on IVF and IUI technologies, thereby increasing the number of fertility treatment procedures. A cultural shift in the form of same-sex marriage in key economies across the world, is, in turn, found to establish a potent revenue source for the assisted reproductive technology market.
Studying the relevance of all the crucial dynamics, Fact.MR, in its latest study, forecasts that revenue of the assisted reproductive technology market would witness an annual increase of around 6.3% in 2020.
For detailed insights on market taxonomy, request a sample copy of the report here.
Fresh Non-donor Fertility Procedures are Deemed Highly Suitable
Adverse effects of demanding lifestyles such as mental stress are taking a toll on the reproductive system of men and women, equally. According to the Centres for Disease Control and Prevention (CDC), nearly 82% of pregnancies resulting from ART cycles use fresh non-donor eggs; the chief reason being, the desire for producing a child using one’s eggs. The trend of using fresh non-donor eggs is especially prominent among women aged less than 35 years.
However, considering delayed family planning and growing influence of chronic diseases such as cancer, medical professionals recommend the medical freezing of eggs for women with a high risk of infertility. Major employers are also taking initiatives to help employees tackle their infertility issues through incentives and perks on the storage of their eggs, which is projected to increase the demand for frozen non-donor procedures. For instance, Facebook, Inc. and Apple Inc. have initiated programs that offer special perks to female employees to store their eggs.
Fertility Clinics Scoring Well in Assisted Reproductive Technology Market
Numerous treatment cycles of infertility treatment using assisted reproductive technology turn the procedure highly expensive. Fertility clinics are magnifying their focus on offering one-stop solutions, ranging from diagnostics to treatment. Investments have also increased towards the development of separate semen and embryology labs to ensure a stable, pathogen-free, and non-toxic environment for gamete handling. Focus of medical professionals of fertility clinics has been on offering quality service to patients by leveraging advanced technology, which, in turn, is boosting the demand for neoteric equipment and devices from fertility clinics. Considering these influences, in 2020 alone, fertility clinics are projected to contribute around US$ 16.8 Bn revenue to the assisted reproductive technology market, which is the highest as compared to hospitals and centres offering similar services.
For detailed regional analysis, request a sample copy of the report here.
Cross-border Reproductive Care Turning into a Phenomena in Assisted Reproductive Technology Market
The study finds that, variations in reimbursement facilities, cost, and patient outcomes in various countries lead to differences in the use of assisted reproductive technology. As per a study published by Springer, 53% of individuals in the Netherlands opt to go abroad to receive quality treatment. Additionally, around 57% to 80% individuals consider legal restriction as one of the chief causes, owing to which, they seek cross-border reproductive care in European countries such as Denmark, Spain, and Switzerland. High-quality fertility treatment services in tandem with the use of advanced technology is creating a favourable growth environment for the European assisted reproductive technology market.
Assisted Reproductive Technology Market – Scope of the Study
The study on the assisted reproductive technology market is an exclusive report published by Fact.MR, which brings to the fore crucial parameters that are driving the growth of the market. This exclusive study provides incisive insights regarding the recent developments in the assisted reproductive technology market, by analysing the historical data for the period of 2015-2019, and 2020-2025 as the forecast period.
Estimation of the revenue of the assisted reproductive technology market has been carried out in terms of value (US$ Mn). This research provides information into the key trends that have the potential to influence the growth of the assisted reproductive technology market. Besides this, the study also includes several macroeconomic and microeconomic growth indicators complementing the growth of the assisted reproductive technology market during the forecast period. This insightful report offers the key dynamics, and their impact on the value chain, which are projected to influence the future growth of the assisted reproductive technology market.
The report also provides information into the key challenges and threats that could deter the growth potential of players in the assisted reproductive technology market. The study unveils profitable opportunities for manufacturers, which they can adopt to strengthen their position in the global assisted reproductive technology market. With a view of aiding stakeholders in the assisted reproductive technology market, the study comprises a detailed section on the competition analysis.
This exclusive study offers a dashboard view of the assisted reproductive technology market, with detailed information about the market players, based on overall revenue, key developments, and their market presence. Additionally, the key strategies of players in the assisted reproductive technology market have also been included in this comprehensive study.
Assisted Reproductive Technology Market – Assessment of Key Segments
Authors of this comprehensive study have classified the assisted reproductive technology market into key segments for an in-depth study of the market. Categorisation of the assisted reproductive technology market is based on procedure, technology, end user, and region. This detailed study also offers information about the incremental opportunity present in the assistive reproductive technology market during the forecast period. Key segments considered while studying the assisted reproductive technology market include:
|
Procedure |
Technology |
End User |
Region |
|
Frozen Donor |
In-vitro Fertilization
|
Fertility Clinics |
North America |
|
Frozen Non-donor |
Surrogacy |
Hospitals |
Europe |
|
Fresh Donor |
Artificial Insemination
|
Others |
Asia Pacific |
|
Fresh Non-donor |
Others |
|
Latin America |
|
Embryo Banking |
|
|
Middle East and Africa |
Authors of the report have taken ample care to track the latest movement of the assisted reproductive technology market, to ensure that only accurate information reaches stakeholders. The study helps these stakeholders in gaining an edge over their competitors. This exclusive guide also tracks the current as well as future trends that are likely to influence the growth of the assisted reproductive technology market during the forecast period.
A list of key companies featured in this study on the assisted reproductive technology market includes Merck KGaA, Esco Micro Pte. Ltd., CooperSurgical, Inc., Planer PLC, Vitrolife AB, Laboratoire CCD, Hamilton Thorne, Inc., Irvine Scientific, Nikon Corporation, and Nidacon International AB. In-depth information about the winning imperatives, threat of new entrants, and substitutes has also been included in this study.
Assisted Reproductive Technology Market – Research Methodology
The primary objective of this exclusive study on the assisted reproductive technology market is to offer precise estimates and forecasts of the market in terms of value (US$ Mn) for the period of 2020-2025. The secondary objective includes analysis of key market segments exhibiting significant growth rates, leading strategies adopted by players in the assisted reproductive technology market, and recalibrate the adoption rate of assisted reproductive technology in key regions across the world.
Request Research Methodology of this report.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Assisted Reproductive Technology Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Key Market Indicators
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunity
4.5. Global Assisted Reproductive Technology Market Analysis and Forecasts, 2020–2025
4.5.1. Market Revenue Projections (US$ Mn)
4.6. Assisted Reproductive Technology Market - Global Supply Demand Scenario
4.7. Porter’s Five Force Analysis
4.8. Market Outlook
4.9. Assisted Reproductive Technology: Regional Funding Scenario
4.10. In Vitro Fertilization Costs, by Region, 2016
4.11. Assisted Reproductive Technology: Indication
5. Global Assisted Reproductive Technology Market Analysis and Forecasts, By Technology
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Key Trends
5.4. Market Value Forecast By Technology, 2020–2025
5.4.1. In Vitro Fertilization
5.4.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
5.4.1.2. Preimplantation Genetic Diagnosis (PGD)
5.4.2. Artificial Insemination
5.4.2.1. Intrauterine Insemination (IUI)
5.4.2.2. Intracervical Insemination (ICI)
5.4.2.3. Others
5.4.3. Surrogacy
5.4.4. Others
5.5. Market Attractiveness By Technology
6. Global Assisted Reproductive Technology Market Analysis and Forecasts, By Procedure
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Key Trends
6.4. Market Value Forecast By Procedure, 2020–2025
6.4.1. Frozen Donor
6.4.2. Frozen Non Donor
6.4.3. Fresh Donor
6.4.4. Fresh Non Donor
6.4.5. Embryo Banking
6.5. Market Attractiveness By Procedure
7. Global Assisted Reproductive Technology Market Analysis and Forecasts, By End User
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Key Trends
7.4. Market Value Forecast By End User, 2020–2025
7.4.1. Fertility Clinics
7.4.2. Hospitals
7.4.3. Others
7.5. Market Attractiveness By End User
8. Global Assisted Reproductive Technology Market Analysis and Forecasts, By Region
8.1. Key Findings
8.2. Policies and Regulations
8.3. Market Value Forecast By Region
8.3.1. North America
8.3.2. Europe
8.3.3. Asia Pacific
8.3.4. Latin America
8.3.5. Middle East and Africa
8.4. Market Attractiveness By Country/Region
9. North America Assisted Reproductive Technology Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.1.2. Policies and Regulations
9.1.3. Key Trends
9.2. Market Value Forecast By Technology , 2020–2025
9.2.1. In Vitro Fertilization
9.2.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
9.2.1.2. Preimplantation Genetic Diagnosis (PGD)
9.2.2. Artificial Insemination
9.2.2.1. Intrauterine Insemination (IUI)
9.2.2.2. Intracervical Insemination (ICI)
9.2.2.3. Others
9.2.3. Surrogacy
9.2.4. Others
9.3. Market Value Forecast By Procedure , 2020–2025
9.3.1. Frozen Donor
9.3.2. Frozen Non Donor
9.3.3. Fresh Donor
9.3.4. Fresh Non Donor
9.3.5. Embryo Banking
9.4. Market Value Forecast By End User , 2020–2025
9.4.1. Fertility Clinics
9.4.2. Hospitals
9.4.3. Others
9.5. Market Value Forecast By Country , 2020–2025
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Technology
9.6.2. By Procedure
9.6.3. By End User
9.6.4. By Country
10. Europe Assisted Reproductive Technology Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.1.2. Policies and Regulations
10.1.3. Key Trends
10.2. Market Value Forecast By Technology , 2020–2025
10.2.1. In Vitro Fertilization
10.2.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
10.2.1.2. Preimplantation Genetic Diagnosis (PGD)
10.2.2. Artificial Insemination
10.2.2.1. Intrauterine Insemination (IUI)
10.2.2.2. Intracervical Insemination (ICI)
10.2.2.3. Others
10.2.3. Surrogacy
10.2.4. Others
10.3. Market Value Forecast By Procedure , 2020–2025
10.3.1. Frozen Donor
10.3.2. Frozen Non Donor
10.3.3. Fresh Donor
10.3.4. Fresh Non Donor
10.3.5. Embryo Banking
10.4. Market Value Forecast By End User , 2020–2025
10.4.1. Fertility Clinics
10.4.2. Hospitals
10.4.3. Others
10.5. Market Value Forecast By Country , 2020–2025
10.5.1. Germany
10.5.2. France
10.5.3. U.K.
10.5.4. Spain
10.5.5. Italy
10.5.6. Russia
10.5.7. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Technology
10.6.2. By Procedure
10.6.3. By End User
10.6.4. By Country
11. Asia Pacific Assisted Reproductive Technology Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.1.2. Policies and Regulations
11.1.3. Key Trends
11.2. Market Value Forecast By Technology, 2020–2025
11.2.1. In Vitro Fertilization
11.2.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
11.2.1.2. Preimplantation Genetic Diagnosis (PGD)
11.2.2. Artificial Insemination
11.2.2.1. Intrauterine Insemination (IUI)
11.2.2.2. Intracervical Insemination (ICI)
11.2.2.3. Others
11.2.3. Surrogacy
11.2.4. Others
11.3. Market Value Forecast By Procedure, 2020–2025
11.3.1. Frozen Donor
11.3.2. Frozen Non Donor
11.3.3. Fresh Donor
11.3.4. Fresh Non Donor
11.3.5. Embryo Banking
11.4. Market Value Forecast By End User, 2020–2025
11.4.1. Fertility Clinics
11.4.2. Hospitals
11.4.3. Others
11.5. Market Value Forecast By Country, 2020–2025
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Technology
11.6.2. By Procedure
11.6.3. By End User
11.6.4. By Country
12. Latin America Assisted Reproductive Technology Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.1.2. Policies and Regulations
12.1.3. Key Trends
12.2. Market Value Forecast By Technology , 2020–2025
12.2.1. In Vitro Fertilization
12.2.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
12.2.1.2. Preimplantation Genetic Diagnosis (PGD)
12.2.2. Artificial Insemination
12.2.2.1. Intrauterine Insemination (IUI)
12.2.2.2. Intracervical Insemination (ICI)
12.2.2.3. Others
12.2.3. Surrogacy
12.2.4. Others
12.3. Market Value Forecast By Procedure , 2020–2025
12.3.1. Frozen Donor
12.3.2. Frozen Non Donor
12.3.3. Fresh Donor
12.3.4. Fresh Non Donor
12.3.5. Embryo Banking
12.4. Market Value Forecast By End User , 2020–2025
12.4.1. Fertility Clinics
12.4.2. Hospitals
12.4.3. Others
12.5. Market Value Forecast By Country , 2020–2025
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Technology
12.6.2. By Procedure
12.6.3. By End User
12.6.4. By Country
13. Middle East and Africa Assisted Reproductive Technology Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.1.2. Policies and Regulations
13.1.3. Key Trends
13.2. Market Value Forecast By Technology , 2020–2025
13.2.1. In Vitro Fertilization
13.2.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
13.2.1.2. Preimplantation Genetic Diagnosis (PGD)
13.2.2. Artificial Insemination
13.2.2.1. Intrauterine Insemination (IUI)
13.2.2.2. Intracervical Insemination (ICI)
13.2.2.3. Others
13.2.3. Surrogacy
13.2.4. Others
13.3. Market Value Forecast By Procedure , 2020–2025
13.3.1. Frozen Donor
13.3.2. Frozen Non Donor
13.3.3. Fresh Donor
13.3.4. Fresh Non Donor
13.3.5. Embryo Banking
13.4. Market Value Forecast By End User , 2020–2025
13.4.1. Fertility Clinics
13.4.2. Hospitals
13.4.3. Others
13.5. Market Value Forecast By Country , 2020–2025
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East and Africa
13.6. Market Attractiveness Analysis
13.6.1. By Technology
13.6.2. By Procedure
13.6.3. By End User
13.6.4. By Country
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis By Company (2016)
14.3. ART Service Providers: Market Snapshot
14.4. Company Profiles
14.4.1. Merck KGaA
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Recent Developments
14.4.1.4. Strategy
14.4.2. CooperSurgical, Inc.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Recent Developments
14.4.2.4. Strategy
14.4.3. Irvine Scientific.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Recent Developments
14.4.3.4. Strategy
14.4.4. Vitrolife AB.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Recent Developments
14.4.4.4. Strategy
14.4.5. Hamilton Thorne, Inc.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Recent Developments
14.4.5.4. Strategy
14.4.6. Nikon Corporation
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Recent Developments
14.4.6.4. Strategy
14.4.7. Nidacon International AB
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Recent Developments
14.4.7.4. Strategy
14.4.8. Laboratoire CCD
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Recent Developments
14.4.8.4. Strategy
14.4.9. Planer PLC
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Recent Developments
14.4.9.4. Strategy
14.4.10. Esco Micro Pte. Ltd. (Esco Group)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Recent Developments
14.4.10.4. Strategy
Fact.MR offers custom research services that help clients to get specific research solutions
Related reports
We are committed towards customer satisfaction and quality service.
Assisted Reproductive Technology Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025